Molecular mechanism underlying the increased risk of colorectal cancer metastasis caused by single nucleotide polymorphisms in LI-cadherin gene.

Humans Cadherins / genetics Cell Adhesion / genetics Colorectal Neoplasms / pathology Lymphatic Metastasis / genetics Polymorphism, Single Nucleotide

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 04 2023
Historique:
received: 04 12 2022
accepted: 28 03 2023
medline: 24 4 2023
pubmed: 21 4 2023
entrez: 20 04 2023
Statut: epublish

Résumé

LI-cadherin is a member of the cadherin superfamily. LI-cadherin mediates Ca

Identifiants

DOI: 10.1038/s41598-023-32444-4 PMID: 37081068 PMC: PMC10117238
pubmed: 37081068
doi: 10.1038/s41598-023-32444-4
pii: 10.1038/s41598-023-32444-4
pmc: PMC10117238
doi:

Substances chimiques

Cadherins 0
CDH17 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6493

Informations de copyright

© 2023. The Author(s).

Références

Gut. 2001 Jul;49(1):73-81
pubmed: 11413113
J Cancer Res Clin Oncol. 2010 Nov;136(11):1641-9
pubmed: 20204409
World J Gastroenterol. 2012 Dec 28;18(48):7251-61
pubmed: 23326130
Structure. 2016 Sep 6;24(9):1523-36
pubmed: 27545624
J Cell Sci. 1976 Dec;22(3):685-95
pubmed: 828165
J Cell Sci. 2012 Oct 1;125(Pt 19):4417-22
pubmed: 23165231
Cell Mol Life Sci. 2004 May;61(10):1157-66
pubmed: 15141301
Cancer Lett. 2019 Jul 10;454:204-214
pubmed: 31004701
J Mol Biol. 2007 Oct 19;373(2):401-11
pubmed: 17850815
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
Nat Struct Mol Biol. 2010 Mar;17(3):348-57
pubmed: 20190754
J Cell Biol. 1994 Jun;125(6):1353-69
pubmed: 8207063
Nature. 1995 Mar 23;374(6520):327-37
pubmed: 7885471
Tissue Barriers. 2017 Apr 3;5(2):e1285390
pubmed: 28452574
J Biol Chem. 2021 Sep;297(3):101054
pubmed: 34364873
Oncotarget. 2016 Sep 27;7(39):64168-64181
pubmed: 27580354
J Biochem. 2017 Oct 1;162(4):255-258
pubmed: 28981752
Gastroenterology. 2002 Nov;123(5):1565-77
pubmed: 12404231
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
F1000Res. 2018 Aug 1;7:
pubmed: 30135716
J Mol Biol. 2000 Jun 9;299(3):551-72
pubmed: 10835267
Dev Biol. 1979 May;70(1):206-16
pubmed: 110634
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
J Clin Oncol. 2005 Dec 1;23(34):8706-12
pubmed: 16314630
Cell Mol Life Sci. 2006 Jul;63(13):1564-73
pubmed: 16791429
J Comput Chem. 2011 Nov 15;32(14):3135-41
pubmed: 21815173
Nature. 1996 Mar 28;380(6572):360-4
pubmed: 8598933
EMBO J. 1988 Dec 1;7(12):3679-84
pubmed: 3061804
Nature. 2019 Sep;573(7774):439-444
pubmed: 31485072
Acta Crystallogr F Struct Biol Commun. 2021 Mar 1;77(Pt 3):85-94
pubmed: 33682793
Cancer Res. 2011 Feb 15;71(4):1214-8
pubmed: 21212413
EMBO J. 1989 Jun;8(6):1711-7
pubmed: 2788574

Auteurs

Anna Yui (A)

Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan.

Daisuke Kuroda (D)

Medical Device Development and Regulation Research Center, School of Engineering, The University of Tokyo, Tokyo, Japan.
Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.

Takahiro Maruno (T)

Department of Biotechnology, Graduate School of Engineering, Osaka University, Osaka, Japan.
U-Medico Inc., Osaka, Japan.

Makoto Nakakido (M)

Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan.

Satoru Nagatoishi (S)

Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Susumu Uchiyama (S)

Department of Biotechnology, Graduate School of Engineering, Osaka University, Osaka, Japan.

Kouhei Tsumoto (K)

Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan. tsumoto@bioeng.t.u-tokyo.ac.jp.
Institute of Medical Science, The University of Tokyo, Tokyo, Japan. tsumoto@bioeng.t.u-tokyo.ac.jp.
Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Tokyo, Japan. tsumoto@bioeng.t.u-tokyo.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Molecular mechanism underlying the increased...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes de surface › Molécules d'adhérence cellulaire › Cadhérines › Molecular mechanism underlying the increased...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Adhérence cellulaire › Molecular mechanism underlying the increased...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies intestinales › Maladies du rectum › Tumeurs colorectales › Molecular mechanism underlying the increased...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Métastase tumorale › Métastase lymphatique › Molecular mechanism underlying the increased...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Polymorphisme génétique › Polymorphisme de nucléotide simple › Molecular mechanism underlying the increased...